Tokyo, Oct. 30 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063463) titled 'Understanding how safe and sustainable oral anticancer therapy management is supported: a realist review' on Oct. 29.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - Kindai University
Condition:
Condition - Management of oral anticancer therapy in people with cancer, without restriction to a single malignancy, stage, treatment intention or regimen.
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To develop and refine an explanatory programme theory of how patients, families and healthcare services accomplish different aspects of oral anticanc...